15 CUSHING, IRVINE, CA
Reports Q1 2026 Results and Update on Progress Toward GraftAssure Commercialization
Amended material disclosure
Annual Report to Security Holders
News, Articles of Incorporation
Financial Results, Press Release
Insight Molecular Diagnostics Enters Specimen Collection Agreement with Quest...
Announces $26.0 Million Registered Direct Offering
Investor Presentation
Q1
Q3
Q2
FY 2024
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
S-1
Notice of Exempt Offering of Securities
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Amended Schedule 13D - Ownership Report
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload